"The US Food and Drug Administration (FDA) has approved Akorn Inc's phenylephrine hydrochloride ophthalmic solution (2.5% and 10%), the company has announced.
The alpha-1 adrenergic receptor agonist is commonly used by optometrists, ophtha"...
Aerobic Gram-Positive Bacteria
Aerobic Gram-Negative Bacteria
*Efficacy for this organism was studied in fewer than 10 infections.
DOSAGE AND ADMINISTRATION
Patients 1 year of age or older: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times on Day 1. Instill one drop two to four times daily in the affected eye(s) while awake on Days 2 through 7.
Dosage Forms And Strengths
Five (5) mL bottle containing 2.5 mL of a 0.5% sterile topical ophthalmic solution.
Storage And Handling
ZYMAXID® (gatifloxacin ophthalmic solution) 0.5% is supplied sterile in a white, low density polyethylene (LDPE) bottle with a controlled dropper tip, and a tan, high impact polystyrene (HIPS) cap in the following size:
2.5 mL in 5 mL bottle: NDC 0023-3615-25
Store at 15°-25°C (59°-77°F). Protect from freezing.
Allergan, Inc, Irvine, CA 92612, U.S.A. Revised: Jan 2014This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 11/9/2016
Additional Zymaxid Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.